Sermorelin – 5mg

Sermorelin (GHRH 1-29 NH₂) is a synthetic peptide fragment that represents the biologically active portion of growth hormone–releasing hormone (GHRH). In research settings, Sermorelin is used to investigate pituitary function, GH pulsatility, and endocrine signaling pathways involved in the regulation of growth hormone secretion.

Our Sermorelin 5 mg peptides in Colombia are manufactured to high-purity, laboratory-grade standards, handled in sterile environments, and packaged in tamper-evident vials for accurate and consistent experimental work.

Key Features

• Quantity: 5 mg Sermorelin (GHRH 1-29 NH₂)
• High-purity, research-grade formulation
• Sterile, tamper-evident packaging
• Manufactured under strict sanitary conditions
• Clear labeling for precise identification
• Free nationwide shipping in Colombia

Applications in Research

Sermorelin is widely employed in studies examining:

• Endogenous GHRH receptor activation and GH release dynamics
• Feedback control within the hypothalamic–pituitary–somatotropic axis
• Interactions between GHRH and ghrelin-mediated secretagogues (e.g., Ipamorelin, GHRP-6)
• Comparative endocrine and metabolic pathway modeling

Technical Information

• Compound: Sermorelin (GHRH 1-29 NH₂)
• Chemical Formula: C₁₄₉H₂₄₆N₄₄O₄₂S
• Molecular Weight: ~3357 Da
• CAS Number: 86168-78-7
• Form: White lyophilized powder
• Purity: ≥ 98% (HPLC-verified)
• Storage: Keep lyophilized peptide refrigerated (2–8 °C) and protected from light / moisture.

References

• Thorner MO et al. “The role of growth hormone–releasing hormone in stimulating GH secretion in humans.” Endocr Rev. 1984.
• Walker RF et al. “Characterization of GHRH (1-29) NH₂ as a diagnostic tool for GH secretion.” J Clin Endocrinol Metab. 1986.
• PubChem Database – Sermorelin (CID 16132332)